Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 6, 2005, Pages 1219-1231

  Chen, Jun Xia ^a   Gao, Ying ^a   Liu, Ji Wei ^a   Tian, Yu Xiang ^a   Zhao, Jing ^b   Cui, Xiu Yun ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Apoptosis; B16 cells; Gene transfer; Ribonuclease inhibitor

Indexed keywords

COMPLEMENTARY DNA; ENZYME INHIBITOR; HUMAN RIBONUCLEASE INHIBITOR; RETROVIRUS VECTOR; RIBONUCLEASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DENSITY; DRUG EFFECT; GENE TARGETING; GENETIC TRANSFECTION; INTERMETHOD COMPARISON; LATENT PERIOD; MALE; MELANOMA CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; VIRAL GENE THERAPY;

MURINAE;

EID: 15044342346     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.11.020     Document Type: Article

References (30)

1. D. Aharoni, A. Dantes, M. Oren, and A. Amsterdam AMP-mediated signals as determinants for apoptosis in primary granulosa cells Experimental Cell Research 218 1995 271 282
2. + endonuclease DNAS1L3 Pharmacology and Toxicology 94 2004 19 29
3. B.G. Campling, J. Pym, H.M. Baker, S.P. Cole, and Y.M. Lam Chemosensitivity testing of small cell lung cancer using the MTT assay British Journal of Cancer 63 1991 75 83
4. E.A. Collisson, A. De, H. Suzuki, S.S. Gambhir, and M.S. Kolodney Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade1,2 Cancer Research 63 2003 5669 5673
5. D. Cronin, C. Daly, T. O'Doherty, M. Heenan, K.J. Scanlon, and M. Clynes Construction and transfection of a ribozyme targeting human caspase-3 Anticancer Research 24 2004 425 431
6. C. Cuadros, A.L. Dominguez, G.L. Frost, P. Borgstrom, and J. Lustgarten Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice Cancer Research 63 2003 5895 5901
7. J. Drevs, C. Laus, M. Mendinger, G.C. Schmidt, and C. Unger Antiangiogenesis: current clinical data and future perspectives Onkologie 25 2002 520 527
8. R.B. Estrada, G. Malet, F. Revert, F. Dasi, A. Crespo, and O. Sanmartin Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin Cancer Gene Therapy 8 2001 278 284
9. M.C. Haigis, E.L. Kurten, and R.T. Raines Ribonuclease inhibitor as an intracellular sentry Nucleic Acids Research 31 2003 1024 1032
10. H.A. Hanford, C.A. Wong, H. Kassan, D.L. Cundiff, N. Chandel, and S. Underwood Angiostatin4.5-mediated apoptosis of vascular endothelial cells Cancer Research 63 2003 4275 4280
11. J. Hofsteenge Ribonuclease inhibitor G. D'Alessio J.F. Riordan Ribonuclease: Structures and Functions 1997 Academic Press New York 621 623
12. B. Kobe, and J. Deisenhofer Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats Nature 366 1993 751 756
13. A.L. Kung, A. Zetterberg, S.W. Sherwood, and R.T. Schimke Cytotoxic effects of cell cycle phase specific agent: result of cell cycle perturbation Cancer Research 50 1990 7307 7317
14. F.S. Lee, R. Shapiro, and B.L. Vallee Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor Biochemistry 28 1989 225 230
15. A. Matter Tumor angiogenesis as a therapeutic target Drug Discovery Today 6 2001 1005 1024
16. A.C. Papageorgiou, R. Shapiro, A.C. Papageorgiou, R. Shapiro, and K.R. Acharya Molecular recognition of human angiogenin by placental ribonuclease inhibitor EMBO Journal 16 1997 5162 5177
17. S.H. Park, and R.T. Raines Genetic screen to dissect protein-protein interactions: ribonuclease inhibitor-ribonuclease A as a model system Methods 28 2002 346 352
18. I.J. Polakowski, M.K. Lewis, V.R. Muthukkaruppan, B. Erdman, L. Kubai, and R. Auerbach A ribonuclease inhibitor expression anti-angiogenic properties and leads to reduced tumor growth in mice American Journal of Pathology 143 1993 507 517
19. S.M. Rybak, E. Sanovich, M.G. Hollingshead, S.D. Borgel, D.L. Newton, and G. Melillo "Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies Cancer Research 63 2003 2812 2819
20. S. Sabbioni, G. Barbanti-Brodano, C.M. Croce, and M. Negrini GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development Cancer Research 57 1997 4493 4497
21. R. Schneider, E. Schneider-Scherzer, M. Thurnher, B. Auer, and M. Schweiger The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module EMBO Journal 7 1988 4151 4156
22. R. Shapiro, M. Ruiz-Gutierrez, and C.Z. Chen Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot" Journal of Molecular Biology 302 2000 497 519
23. R. Shapiro Cytoplasmic ribonuclease inhibitor Methods of Enzymology 341 2001 611 628
24. W.W. Spurbeck, C.Y. Ng, E.F. Vanin, and A.M. Davidoff Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice Cancer Gene Therapy 10 2003 161 167
25. N.A. Thornberry, and Y. Lazebnik Caspase: enemies within Science 281 1998 1312 1316
26. Y.X. Tian, D.M. Wang, and X.Y. Cui Analysis of gene expression of ribonuclease inhibitor in human breast cancer tissue Ai Zheng 23 2004 269 272 (Chinese)
27. S.A. Vantyghem, C.O. Postenka, and A.F. Chambers Estrous cycle influences organ-specific metastasis of B16F10 melanoma cells Cancer Research 63 2003 4763 4765
28. M. Weiss, S. Hettmer, P. Smish, and S. Ladisch Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase Cancer Research 63 2003 3654 3658
29. B.B. Wolf, and D.R. Green Suicidal tendencies: apoptotic cell death by caspase family proteinases Journal of Biological Chemistry 274 1999 20049 20052
30. L.Q. Yang, D.C. Fang, R.Q. Wang, and S.M. Yang Effect of NF-kappaB, surviving, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand World Journal of Gastroenterology 10 2004 22 25